• SENSEX 74,529.08
    -329.91 (--0.44%)
  • BANKNIFTY 56,215.55
    -255.10 (--0.45%)
  • Pine Labs
    205.00 283.70(%)
  • HDFC Bank
    738.70 682.00(%)
  • Meesho
    244.80 254.65(%)
  • Glass Wall Syst.
    318.00 318.00(%)
  • Cholaman.Inv.&Fn
    1,756.50 1,299.80(%)
  • Solar Industries
    20,243.65 22,630.05(%)
  • Cupid
    265.35 298.95(%)
  • Aster DM Quality
    746.55 519.80(%)
  • Protean eGov
    656.45 940.00(%)
  • Gabriel India
    1,495.35 1,600.00(%)
  • Nippon ETF Liq.
    999.99 978.01(%)
  • Transrail Light
    487.90 800.35(%)
  • Reliance Industries
    1,237.80 1,232.35(%)
  • JSW Dulux
    3,131.20 2,649.05(%)
  • Kaynes Tech
    3,427.35 2,995.85(%)
  • Apar Inds.
    17,916.55 6,800.00(%)
  • Titan Company
    4,983.70 5,187.45(%)
  • Dixon Technolog.
    12,997.00 9,605.05(%)
  • Eternal
    341.80 368.40(%)
  • Larsen & Toubro
    3,867.50 3,288.65(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Sunrest Lifescience Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 91669.0
  • ISIN : INE0PLZ01012
38.45 2 (4.63%)
  • As on 23 Sep 2026 (EOD)

  • Today’s Low

    36.95

  • Today’s High

    38.45

  • Open

    36.95

  • Perv Close

    36.75

  • 52W Low

    27.54

  • 52W High

    50.33

Key Indicators

  • P/E(TTM)

    5.34

  • Mar.Cap (₹Cr.)

    16.50

  • Div & Yield %

    0.00

  • Book Value(₹)

    44.91

  • Debt-Equity Ratio

    4.63

  • AGM Date

    22-Sep-2026

  • EPS

    7.20

  • P/E Ratio

    5.34

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    16.50

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    4.29

  • BV (₹)

    44.90

  • Sales( ₹ in Cr.)

    33.26

  • NP (in Cr.)

    3.09

  • NP Var(%)

    54.0

  • Div%

    0.0

  • CPS (₹)

    7.70

  • EPS (₹)

    7.20

  • Traded Value (₹ in Lakhs)

    16.50

  • 52 Week High

    50.33

  • 52 Week Low

    27.54

  • Price BSE

    0.0

  • Price NSE

    38.00

  • Market Capital( in Cr.)

    16.50

  • P/C Ratio

    4.90

  • P/E Ratio

    5.30

  • Price Vs.BV

    7.20

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 33.12 29.48 24.64 26.89 16.95 10.95
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 33.12 29.48 24.64 26.89 16.95 10.95
Other Income 0.00 0.00 0.03 0.02 0.00 0.00
Stock Adjustments 1.73 1.11 1.65 0.77 1.05 -0.02
Total Income 34.85 30.59 26.32 27.68 18.00 10.93
EXPENDITURE :            
Raw Materials 21.58 21.09 16.52 18.24 12.40 7.37
Power and Fuel Cost 0.01 0.01 0.01 0.00 0.01 0.00
Employee Cost 4.21 3.59 2.90 2.54 2.37 2.06
Other Manufacturing Expenses 0.02 0.54 0.03 0.04 0.13 0.05
Selling and Administration Expenses 5.98 4.39 3.27 4.54 2.67 1.26
Miscellaneous Expenses 0.05 0.07 0.65 1.19 0.15 0.04
Employee Benefit Expenses 4.21 3.59 2.90 2.54 2.37 2.06
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 31.86 29.69 23.38 26.55 17.72 10.78
Operating Profit 3.00 0.91 2.93 1.13 0.28 0.15
Interest 0.30 0.22 0.06 0.02 0.01 0.00
Gross Profit 2.70 0.69 2.87 1.11 0.27 0.15
Depreciation 0.09 0.10 0.13 0.06 0.04 0.02
Profit Before Tax 2.61 0.59 2.74 1.05 0.23 0.13
Current Tax 0.61 0.37 0.71 0.27 0.06 0.10
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 -0.01 -0.01 0.00 -0.01 0.00
Reported Net Profit 2.00 0.23 2.04 0.78 0.17 0.04
Extraordinary Items 0.00 0.00 0.00 0.02 0.00 0.00
Adjusted Net Profit 2.00 0.23 2.04 0.76 0.17 0.04
Adjustment below Net Profit 0.00 0.00 -2.99 0.00 0.00 0.00
P & L Balance brought forward 0.34 0.11 1.06 0.28 0.12 0.08
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down 2.34 0.34 0.11 1.06 0.28 0.12
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 4.66 0.53 6.81 777.10 165.50 36.80
Earnings Per Share(Adj)-Unit Curr 4.16 0.49 - - - -
Book Value 37.72 33.06 10.38 1,070.40 294.90 129.40
Book Value(Adj)-Unit Curr 33.66 30.81 - - - -

Shareholding Pattern

  • Promoter Group

    53.50%

  • Public Share Holding

    46.50%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 2,296,000 53.50 2,296,000 7
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 2,296,000 53.50 2,296,000 7
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 0 0.00 0 0
2] Non Institution
Bodies Corporate 286,400 6.67 286,400 15
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 17,600 0.41 17,600 6
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 137,600 3.21 137,600 33
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 622,400 14.50 622,400 10
Individuals holding nominal share capital up to Rs. 1 lakh 923,200 21.51 923,200 412
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 1,995,200 46.50 1,995,200 477
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 4,291,200 100.00 4,291,200 484

Company Background

Sunrest Lifescience LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Sunrest Lifescience Ltd
  • BSE Code : 91669.0
  • ISIN : INE0PLZ01012

  • Incorporation Year

    2017

  • Registered Office

    FF-41 Ajaj Tenament 6 Near Can
    #NAME?, Ahmedabad,
    Gujarat-382415

  • Telephone

    +91-079 29918245

  • FAX

  • Chairman

    Juhi Sawajani

  • Managing Director

  • Company Secretary

    Nabil Ansari

  • Auditor

    Madhusudan C Mashruwala & Co

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    Skyline Financial Services Pvt
    D-153/A 1st Flr,
    Okhla Industrial Are,Phase-I
    Mumbai - New Delhi-110020

Sunrest Lifescience Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Sunrest Lifescie 38.45 33.12 33.12 5.34 13.53
Abbott India 27,223.20 7,217.19 6,929.05 35.83 43.78
Astrazeneca Phar 6,712.15 2,304.07 2,275.58 98.93 27.86
Glaxosmi. Pharma 2,871.50 3,932.76 3,790.20 45.87 58.17
Novartis India 1,976.65 393.10 354.33 49.92 15.94
Cipla 1,381.00 20,102.60 18,979.95 36.29 13.88
Bliss GVS Pharma 690.40 773.53 729.81 64.16 12.51
Amrutanjan Healt 500.25 520.13 502.55 26.79 24.16
Fermenta Biotec. 471.40 474.15 450.25 22.01 18.77
Guj. Themis Bio. 411.75 168.25 165.82 110.09 18.05
Ambalal Sarabhai 38.82 19.52 3.94 71.89 6.77